Latest News
Moutai Shares Drop 2.6% as Liquor Sector Retreats Ahead of Inflation Data
Kweichow Moutai's Class A shares declined 2.6% to 1,515.01 yuan on Friday, leading a broad pullback in baijiu stocks. Investors are now focused on China's upcoming inflation figures for market direction.
CCB Shares Edge Higher as Markets Await Key Chinese Economic Data
China Construction Bank's Class A stock closed slightly higher on Friday, while the broader Shanghai market declined. Investor focus now shifts to upcoming inflation and credit data for policy direction.
PetroChina A-Shares Outperform as Oil Prices Rebound on Geopolitical Tensions
PetroChina's Class A shares rose 2.3% to 10.77 yuan, outpacing the broader Shanghai market decline, as Brent crude climbed to $68.05. Traders are monitoring U.S.-Iran talks and new EU sanctions.
Morgan Stanley Rebounds as Dow Tops 50,000; Focus Shifts to Fed Policy and AI Spending
Morgan Stanley shares gained 2.34% to $179.96 on Friday, ending a three-day decline amid broader market strength. The Dow Jones Industrial Average closed above 50,000 for the first time.
Nestle Shares Gain Amid Formula Recall Scrutiny, Investors Eye Upcoming Earnings
Nestle shares rose 0.6% to 78.89 Swiss francs, outperforming the Swiss market index as investors monitor a widening infant formula recall and await full-year results due February 19.
Goldman Sachs Surges on AI Partnership, Lifts Dow Past 50,000
Goldman Sachs shares climbed 4.3% Friday following confirmation of an AI collaboration with Anthropic, helping propel the Dow Jones Industrial Average above 50,000 for the first time. Key economic data releases and new structured note filings are in focus.
IBM Shares Surge 3% Ahead of Key Confluent Vote and Dividend Date
IBM stock climbed 3.1% to $298.93 on Friday, buoyed by a new defense contract and anticipation of upcoming shareholder events. The gain outpaced several tech peers as markets rebounded.
Philip Morris Lifts 2026 Outlook on Nicotine Pouch Strength, Stock Holds Near $183
Philip Morris International raised its 2026 profit forecast, citing robust nicotine pouch sales. Shares closed at $182.81, up 0.45%, as investors weigh growth against competitive pressures.
Novartis Advances with Canadian Reimbursement and Major U.S. R&D Expansion
Novartis shares gained as the company secured a draft reimbursement nod in Canada for Kisqali and broke ground on a $23 billion U.S. research center. Investors eye upcoming dividend and annual meeting.
AstraZeneca Shares Gain Ahead of Key Earnings Report and 2026 Outlook
AstraZeneca shares advanced in both New York and London trading ahead of its Q4 and full-year 2025 results release. Investors are focused on the company's 2026 guidance and recent regulatory developments.